Results 121 to 130 of about 951,869 (260)
δ-Hydroxy-γ-oxo-L-norvaline, a New Antitubercular Antibiotic. (2). Synthetic Studies.
The structure of δ-hydroxy-γ-oxo-L-norvaline was proposed for the new antibiotic, HON. This compound was synthesized through two different routes. Optical resolution of the racemate was achieved by fractional crystallization of brucine salts of N-acetyl-δ-hydroxy-γ-oxo-DL-norvaline.
openaire +2 more sources
A Prospective Analysis of Adverse Drug Reactions in a South Indian Hospital [PDF]
Adverse drug reactions are a great cause of concern to the medical profession, the patients and the pharmaceutical industry. However ADR reporting and monitoring is yet to catch up in India.
Adhikari, P, Padmaja, U, Pereira, P
core
【Abstract】Tuberculosis (TB) occurring after a closed bone fracture in the patient with no history of TB and no evidence of TB infection at the time of initial fracture is a rare entity.
Habib Masood +3 more
doaj
A Multinational Analysis of Mutations and Heterogeneity in PZase, RpsA, and PanD Associated with Pyrazinamide Resistance in M/XDR Mycobacterium tuberculosis. [PDF]
Pyrazinamide (PZA) is an important first-line drug in all existing and new tuberculosis (TB) treatment regimens. PZA-resistance in M. tuberculosis is increasing, especially among M/XDR cases.
Catanzaro, A +7 more
core +1 more source
Tuberculosis is among the world’s deadliest diseases, causing approximately 2 million deaths annually. The urgent need for new antitubercular drugs has been intensified by the rise of drug-resistant strains.
Jahn Nitschke +2 more
doaj +1 more source
The Hidden Role of Epstein-Barr Virus in Encephalitis: Case Studies of Diagnostic Dilemmas
Epstein-Barr virus (EBV), typically associated with infectious mononucleosis and various malignancies, is an uncommon cause of encephalitis. The role of EBV in conjunction with other central nervous system (CNS) infections remains unclear, though its ...
Anubhav Bansal +2 more
doaj +1 more source
Post Penicillin Antibiotics: From acceptance to resistance? [PDF]
Edited transcript of a Witness Seminar held at the Wellcome Institute for the History of Medicine, in London, on 12 May 1998. First published by the Wellcome Trust, 2000. ©The Trustee of the Wellcome Trust, London, 2000.
Reynolds, LA, Tansey, EM
core

